Brain uptake of thiamine-coated nanoparticles

Journal of Controlled Release

Volumn 93, Issue 3, 2003, Pages 271-282

  Lockman, Paul R ^a   Oyewumi, Moses O ^b   Koziara, Joanna M ^b   Roder, Karen E ^a   Mumper, Russell J ^b   Allen, David D ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b University of Kentucky   (United States)

Author keywords

Biodistribution; Blood brain barrier; Emulsifying wax; Microemulsions; Targeting

Indexed keywords

BLOOD; MICROEMULSIONS; NANOSTRUCTURED MATERIALS; POLYETHYLENE GLYCOLS; WAXES;

EMULSIFYING WAXES; LIGANDS;

BRAIN;

LIGAND; MACROGOL; NANOPARTICLE; OIL; PHOSPHATIDYLETHANOLAMINE; THIAMINE; WATER; WAX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; FEMALE; GEL PERMEATION CHROMATOGRAPHY; ISOTOPE LABELING; KINETICS; MALE; MICROEMULSION; MOUSE; NONHUMAN; PERFUSION; PRECURSOR; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0344009673     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.08.006     Document Type: Article

References (25)

1. Pardridge W.M. Drug and gene delivery to the brain: the vascular route. Neuron. 36(4):2002;555-558.
2. Brightman M.W. Morphology of blood-brain interfaces. Exp. Eye Res. 25:1977;1-25. (Suppl.).
3. Pardridge W.M. Brain drug targeting and gene technologies. Jpn. J. Pharmacol. 87(2):2001;97-103.
4. Terasaki T. Development of brain efflux index (BEI) method and its application to the blood-brain barrier efflux transport study. Pardridge W.M. Introduction to the Blood-Brain Barrier. 1998;24-31 Cambridge Univ. Press, New York.
5. Lockman P.R., Mumper R.J., Khan M.A., Allen D.D. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28(1):2002;1-12.
6. Kreuter J., Alyautdin R.N. Using nanoparticles to target drugs to the central nervous system. Begley D.J., Bradbury M.W., Kreuter J. The Blood-Brain Barrier and Drug Delivery to the CNS. 2000;205-223 Marcel Dekker, New York.
7. Gulyaev A., Gelperina S.E., Skidan I.N., Antropov A.S., Kivman G.Y., Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80 coated nanoparticles. Pharm. Res. 16(10):1999;1564-1569.
8. Schroder U., Sabel B.A. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res. 710(1-2):1996;121-124.
9. Alyautidin R.N., Tezikov E.B., Ramage P.D., Kharkevich A., Begly D.J., Kreuter J. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated poly(butylcyanoacrylate) nanoparticles: an in-situ brain perfusion study. J. Microencapsul. 15(1):1998;67-74.
10. Koziara J., Lockman P.R., Allen D.D., Mumper R.J. In-situ blood-brain barrier transport of nanoparticles. Pharm. Res. 2003;. in press.
11. Takasato Y., Rappaport S.I., Smith Q.R. An in-situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247:1984;484-493.
12. Lockman P.R., Koziara J., Roder K.E., Paulson J., Abbruscato T.J., Mumper R.J., Allen D.D. In-vivo and in-vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles. Pharm. Res. 20(5):2003;705-713.
13. Vyas S.P., Singh A., Sihorkar V. Ligand-receptor mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit. Rev. Ther. Drug Carr. Syst. 189(1):2001;1-76.
14. Wang S., Low P.S. Folate-mediated targeting of antineoplastic drugs, imaging agents and nucleic acids to cancer cells. J. Control. Release. 53(1-3):1998;39-48.
15. Oyewumi M.O., Liu S., Moscow J.A., Mumper R.J. Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters. Bioconjug. Chem. 14(2):2003;404-411.
16. Lockman P.R., Mumper R.J., Allen D.D. Evaluation of blood-brain barrier thiamine efflux using the in-situ rat brain perfusion method. J. Neurochem. 86(3):2003;637-644.
17. Greenwood J., Love E.R., Pratt O.E. Kinetics of thiamine transport across the blood-brain barrier in the rat. J. Physiol. 327:1982;95-103.
18. Smith Q.R. Drug delivery to the brain and the role of carrier mediated transport. Drewes L.R., Betz A.L. Frontiers in Cerebral Vascular Biology: Transport and its Regulation. 1993;83-93 Plenum, New York.
19. Oyewumi M.O., Mumper R.J. Gadolinium loaded nanoparticles engineered from microemulsion templates. Drug Dev. Ind. Pharm. 28(3):2002;317-328.
20. Smith Q.R. Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system. Pharm. Biotechnol. 8:1996;285-307.
21. Allen D.D., Smith Q.R. Characterization of the blood-brain barrier choline transporter using the in-situ rat brain perfusion technique. J. Neurochem. 76(4):2001;1032-1041.
22. Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharm. Res. 10(7):1993;1093-1095.
23. Mosquieira V.C.F., Legrand P., Morgart J., Vert M., Mysiakine E., Gref R., Devissaguet J., Barrat G. Biodistribution of long-circulating PEG-grafted nano-capsules in mice: effects of Peg chain length and density. Pharm. Res. 18(10):2001;4111-4119.
24. Oyewumi M.O., Mumper R.J. Tumor-targeted delivery of folate-coated gadolinium nanoparticles in athymic nude mice. Proceedings of Annual Conference of Controlled Release Society, Glasgow-Scotland:2003;. Abstract accepted.
25. Brigger I., Morizet J., Auber G., Chacun H., Terrier-Lamcombe M., Couvreur P., Vassal G. Poly(ethylene gycol)-coated hexadecylcyanozcrylate nanosperes display a combined effect for brain tumor targeting. J. Pharmacol. Exp. Ther. 303(3):2002;928-936.